- Home
- CISO vs CCEL Comparison
CISO vs CCEL Comparison
Compare CISO & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- CCEL
- Stock Information
- Founded
- CISO 2015
- CCEL 1989
- Country
- CISO United States
- CCEL United States
- Employees
- CISO N/A
- CCEL N/A
- Industry
- CISO Computer Software: Prepackaged Software
- CCEL Managed Health Care
- Sector
- CISO Technology
- CCEL Health Care
- Exchange
- CISO Nasdaq
- CCEL Nasdaq
- Market Cap
- CISO 31.4M
- CCEL 34.8M
- IPO Year
- CISO N/A
- CCEL 1997
- Fundamental
- Price
- CISO $1.29
- CCEL $4.41
- Analyst Decision
- CISO
- CCEL Strong Buy
- Analyst Count
- CISO 0
- CCEL 1
- Target Price
- CISO N/A
- CCEL $8.50
- AVG Volume (30 Days)
- CISO 685.4K
- CCEL 25.6K
- Earning Date
- CISO 11-17-2025
- CCEL 10-14-2025
- Dividend Yield
- CISO N/A
- CCEL 13.41%
- EPS Growth
- CISO N/A
- CCEL N/A
- EPS
- CISO N/A
- CCEL N/A
- Revenue
- CISO $28,792,765.00
- CCEL $31,988,783.00
- Revenue This Year
- CISO N/A
- CCEL $1.75
- Revenue Next Year
- CISO N/A
- CCEL N/A
- P/E Ratio
- CISO N/A
- CCEL N/A
- Revenue Growth
- CISO N/A
- CCEL 1.10
- 52 Week Low
- CISO $0.30
- CCEL $4.09
- 52 Week High
- CISO $3.84
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- CISO 68.68
- CCEL 45.18
- Support Level
- CISO $1.21
- CCEL $4.26
- Resistance Level
- CISO $1.47
- CCEL $4.70
- Average True Range (ATR)
- CISO 0.11
- CCEL 0.21
- MACD
- CISO 0.04
- CCEL 0.00
- Stochastic Oscillator
- CISO 70.30
- CCEL 33.87
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.